Toronto Digestive Disease Associates, Inc.

Toronto, Ontario M3N2V7

0 studies enrolling now · 7 studies all time

What they study most

Crohn's Disease, Irritable Bowel Syndrome, Ulcerative Colitis

Studies at this site

• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis — Completed
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis — Completed
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS — Completed